{
  "functional_evidence_assessment": [
    {
      "variant_id": {
        "Gene": "LRRK2",
        "Protein_Change": {
          "ref": "G",
          "alt": "S",
          "position": "2019"
        },
        "variant_string_id": "LRRK2 G2019S"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "LRRK2 mutations are currently recognized as the most common genetic cause of parkinsonism.",
          "judgment": "Yes",
          "reasoning": "The paper explicitly states a link between LRRK2 mutations and parkinsonism, establishing a relevant disease mechanism.",
          "next_step_or_outcome": "Proceed to Step 2"
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "We generated transgenic Drosophila over-expressing various human LRRK2 alleles... transgenic flies harboring G2019S... exhibit late-onset loss of dopaminergic (DA) neurons... accompanied by locomotion deficits.",
          "judgment": "Yes",
          "reasoning": "Using a Drosophila model to assess DA neuron loss and locomotion deficits is a relevant and accepted approach to investigate LRRK2-related parkinsonism pathogenesis.",
          "next_step_or_outcome": "Proceed to Step 1"
        },
        {
          "step_name": "Step 1: Variant Controls",
          "extracted_paper_info": "We found that transgenic flies harboring G2019S, Y1699C, or G2385R LRRK2 variant, but not the wild-type protein, exhibit late-onset loss of dopaminergic (DA) neurons.",
          "judgment": "Yes",
          "reasoning": "The study used wild-type (control) and mutant variants.",
          "next_step_or_outcome": "Step 2"
        },
        {
          "step_name": "Step 4: Statistical Analyses",
          "extracted_paper_info": "The paper does not mention OddsPath calculation or other formal statistical analyses, relying on descriptive observations.",
          "judgment": "No",
          "reasoning": "The paper lacks statistical tests or quantitative measures of pathogenicity likelihood.",
          "next_step_or_outcome": "Proceed to Sub-step 4b"
        },
        {
          "step_name": "Sub-step 4b: No OddsPath Calculation",
          "extracted_paper_info": "The study used wild-type (control) and mutant variants in the Drosophila model.",
          "judgment": "N/A",
          "reasoning": "Since statistical analyses were not performed, assess the number of control variants",
          "next_step_or_outcome": "Determine final evidence strength"
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_supporting"
      },
      "overall_conclusion": "The demonstration of DA neuron loss and locomotion deficits in G2019S LRRK2-expressing flies compared to wild-type controls, coupled with the absence of detailed quantitative analysis, supports a supporting level of evidence for pathogenicity."
    }
  ]
}